Skip to main content

Industry expert Jon Hale shares his views on attempts to discredit sustainable investing

Posted on August 14, 2018

Morningstar Sustainalytics
Morningstar Sustainalytics

In a new Medium article highly worth the read, Jon Hale, Global Head, Sustainable Investing Research at Morningstar, writes about recent misleading attacks on the credibility of ESG assessments and sustainable investing. He takes aim at a critical report from The American Council for Capital Formation, a Washington D.C. policy group financed by the National Association of Manufacturers, the fossil fuels industry and various other corporate lobbying organizations.

Jon shares his views on the motivations behind the ACCF’s report and its misinformed conflation of (known) flaws in ESG assessments and the overall validity of sustainable investing. He also counters criticisms of investment managers integrating ESG factors into their investment processes. Jon sets the record straight, pointing out that:

  • Large investment managers are engaging companies on ESG issues because they want to reduce risk and build long-term shareholder value;
  • Investors encouraging companies to look at their broader environmental, social and economic influence can both reduce long-term systemic risks and help create a context in which investments can flourish over the long run;
  • “Main street investors” support sustainable investing and sustainable investors are pressing these issues with companies because it is a path to long-term value creation and a more sustainable world;
  • When Morgan Stanley asked individual investors last year how interested they are in sustainable investing, 75% said they were either somewhat or very interested. And more than 70% agreed that having leading ESG practices can lead a company to higher profitability and make it a better long-term investment.

Read “Attacks on ESG from the Swamp” by Joh Hale.

Recent Content

US, Europe Biopharma Partnerships With Chinese Firms: Evaluating ESG Risks

Examining the ESG and geopolitical risks shaping US and European biopharma partnerships with Chinese firms.

Intensifying US Healthcare Access and Pricing Policy Risks Put Pressure on Sector Companies

Exploring how access and pricing policy risks are intensifying and shifting across the US healthcare value chain.

Regulation in Action

Examining Double Materiality: How Sustainalytics’ CSRD Double Materiality Assessment Tool Can Help Investors

Examining the intersection between subindustries and ESRS topics, from a double materiality perspective.

How Quality Capex Data Can Help Investors Navigate Climate Transition Risk

Presenting an overview of an in-depth discussion hosted by Environmental Finance, where sustainable investment and climate specialists discussed capital allocation as a clear forward-looking signal of transition credibility.